Selected Publications by Medaffcon Oy
These articles, posters and study abstracts represent a subset of the biobank and other real world evidence -based studies conducted by Medaffcon.
Peer-reviewed articles
The burden of hip and knee osteoarthritis in Finnish occupational healthcare, Summanen M, Ukkola-Vuoti L, Kurki S, Tuominen S, Madanat R. BMC Musculoskelet Disord (2021) DOI: 29;22(1):501. https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04372-9.pdf
Characteristics and survival trends in Finnish multiple myeloma patients – a nationwide real-world evidence study, Toppila I, Miettinen T, Lassenius MI, Lievonen J, Bauer M, Anttila P. Ann Hematol (2021). DOI: 10.1007/s00277-021-04481-4. https://doi.org/10.1007/s00277-021-04481-4
The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland, Savolainen MJ, Karlsson A, Rohkimainen S, Toppila I, Lassenius MI, Vaca Falconi C, Uusi-Rauva K and Elomaa K. Molecular Genetics and Metabolism Reports (2021) DOI: 10.1016/j.ymgmr.2021.100725. https://doi.org/10.1016/j.ymgmr.2021.100725
My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland, Sumelahti M-J, Sumanen M, Sumanen MS, Tuominen S, Vikkula J, Honkala SM, Rosqvist S and Korolainen MA. The Journal of Headache and Pain (2020) DOI: 10.1186/s10194-020-01185-4. https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-01185-4
Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure, Huusko J, Tuominen S, Studer R, Corda S, Proudfoot C, Lassenius MI ja Ukkonen H. ESC Heart Failure (2020) DOI: 10.1002/ehf2.12792. https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12792
Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction, Huusko J, Purmonen T, Toppila I, Lassenius M and Ukkonen H. ESC Heart Failure (2020) DOI: 10.1002/ehf2.12665. https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12665
Cardiovascular event rates increase after each recurrence and associate with poor statin adherence, Lassenius MI, Toppila I, Bergius S, Perttilä J, Airaksinen KEJ and Pietilä M. European Journal of Preventive Cardiology (2020) DOI: 10.1177/2047487320904334. https://doi.org/10.1177/2047487320904334
Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare, Korolainen MA, Tuominen S, Kurki S, Lassenius MI, Toppila I, Purmonen T, Santaholma J and Nissilä M. The Journal of Headache and Pain (2020) 21:8. DOI: 10.1186/s10194-020-1077-x. https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-1077-x
Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis, Lassenius MI, Toppila I, Pöntynen N, Kasslin L, Kaunisto J, Kilpeläinen M and Laitinen T. European Clinical Respiratory Journal (2019) 7:1, 1702618, DOI: 10.1080/20018525.2019.1702618. https://www.tandfonline.com/doi/full/10.1080/20018525.2019.1702618
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization, Viinanen A, Lassenius MI, Toppila I, Karlsson A, Veijalainen L, Idänpään-Heikkilä JJ and Laitinen T. International Journal of Chronic Obstructive Pulmonary Disease (2019) 14:2409-2421. https://www.dovepress.com/the-burden-of-chronic-obstructive-pulmonary-disease-copd-in-finland-im-peer-reviewed-article-COPD
The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization, Viinanen A, Lassenius M, Toppila I, Karlsson A, Veijalainen L, Idänpään-Heikkilä J and Laitinen T. Journal of Asthma (2019). DOI: 10.1080/02770903.2019.1633664. https://www.tandfonline.com/doi/full/10.1080/02770903.2019.1633664
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use, Huusko J, Kurki S, Toppila I, Purmoen T, Lassenius M, Gullberg E, Bruce-Wirta S and Ukkonen H. ESC Heart Failure (2019). DOI: 10.1002/ehf2.12443. https://www.ncbi.nlm.nih.gov/pubmed/31054212
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care, Korolainen M, Kurki S, Lassenius M, Toppila I, Costa-Scharplatz M, Purmonen T and Nissilä M. Journal of headache and pain (2019) 20:13. DOI: 10.1186/s10194-019-0964-5. https://rdcu.be/bmtGA
Type 2 diabetes and treatment intensification in primary care in Finland, Niskanen L, Hahl J, Haukka J, Leppä E, Miettinen T, Mushnikov V, Sipilä R, Tamminen N, Vattulainen P and Korhonen P. Acta Diabetologica (2018) 55:1171-1179. https://www.ncbi.nlm.nih.gov/pubmed/30083982
Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland, Mäkelä MJ, Christensen HN, Karlsson A, Rastogi S and Kettunen K. European Clinical Respiratory Journal (2018) 5(1):1458560. https://www.ncbi.nlm.nih.gov/pubmed/29696083
Re-treatment with varenicline is a cost-effective aid for smoking cessation. Kautiainen K, Ekroos H, Puhakka M, Liira H, Laine J, Linden K, Hahl J. J Med Econ. 2017 Mar;20(3):246-252. DOI: 10.1080/13696998.2016.1249485. https://pubmed.ncbi.nlm.nih.gov/27754739/
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis. 2016;19(1):21-33.
Posters or oral presentations at international congresses
The real-world dose differences of insulin glargine 300 U/ml in Finland. Koski L, Hahl J, Kaye S & Pousar K. ISPOR Europe, Nov 2019, Copenhagen, Denmark. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/94970
Migraine comorbidity and phenotypic disease networks in occupational health care. Korolainen M A, Kurki S, Tuominen S, Toppila I, Lassenius M I, Santaholma J, Purmonen T, Nissilä M. 19th Congress of the International Headache Society, Sep 7-8, 2019; Dublin, Ireland.
Study to determine predictive potential of an algorithm for earlier diagnosis of Gaucher disease: Retrospective biobank study utilizing real-world data available in Finland. Savolainen M, Karlsson A, Toppila I, Elomaa K, Panahloo Z, Wolf M. 15th Annual WORLD Symposium, Feb 4-8, 2019; Orlando, Florida, USA.
Health Registry Data Survey for Assessing Characteristics and Descriptive Epidemiology of Patients with Multiple Myeloma in Southwest Finland between 2004—May 2017. Salmi T, Saukkonen K, Wolf, M, Toppila I, Kurki S, Schoonen M, Putkonen M. ESH, 4th International Conference on multiple myeloma, Oct 5-7, 2018; Mandelieu, France.
Health care resource use, sick-leaves and comorbidities among migraine patients in occupational healthcare. Korolainen M A, Kurki S, Toppila I, Lassenius M, Purmonen T, Nissilä M. European Headache federation meeting, Sep 28-30, 2018; Florence, Italy.
Heart Failure in Finland – Evaluating the burden of disease and treatment patterns. Huusko J, Kurki S, Toppila I, Purmonen T, Lassenius M, Gullberg E, Bruce-Wirta S, Ukkonen H. European Society of Cardiology Congress, 2018; Munich, Germany. https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-6-Chronic-heart-failure-epidemiology-prognosis-outcome/179342-heart-failure-in-finland-evaluating-the-burden-of-disease-and-treatment-patterns
Trend towards longer time to reimbursement in oncological medicines in Finland 2005-2015. Oinonen L, Renlund M, Pudas H, Ihalmo P, Hahl J. ISPOR, 2016. https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-19th-annual-european-congress/trend-towards-longer-time-to-reimbursement-in-oncological-medicines-in-finland-2005-2015
The epidemiology of adult immune (idiopathic) thrombocytopenic purpura (ITP) in Finland: resource utilisation, related costs and hospital medication associated with the treatment of non-splenectomised adult ITP based on real world data from Auria biobank. Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017. https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-20th-annual-european-congress/the-epidemiology-of-adult-immune-idiopathic-thrombocytopenic-purpura-itp-in-finland-resource-utilisation-related-costs-and-hospital-medication-associated-with-the-treatment-of-non-splenectomised-adult-itp-based-on-real-world-data-from-auria
Resource utilisation and related health care costs among patients with multiple myeloma with ≥ 2 prior lines of treatment in Finland: evaluation based on Finnish real world data from Auria biobank. Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017. https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-20th-annual-european-congress/resource-utilisation-and-related-health-care-costs-among-patients-with-multiple-myeloma-with-2-prior-lines-of-treatment-in-finland-evaluation-based-on-finnish-real-world-data-from-auria-biobank
Resource use, health care costs and burden of disease in patients with polycythemia vera in Finland: evaluation based on leukocyte counts using Finnish real world data from Auria biobank. Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017. https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-20th-annual-european-congress/resource-use-health-care-costs-and-burden-of-disease-in-patients-with-polycythemia-vera-in-finland-evaluation-based-on-leukocyte-counts-using-finnish-real-world-data-from-auria-biobank
Cost-effectiveness of Pasireotide long-acting in a treatment of acromegaly in Finland. Economic evaluation based on Finnish Auria biobank data on health care resource utilization. Hahl J, Kurki S, Miettinen T, Snicker K. ISPOR, 2015. https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-18th-annual-european-congress/cost-effectiveness-of-pasireotide-long-acting-in-a-treatment-of-acromegaly-in-finland-economic-evaluation-based-on-finnish-auria-biobank-data-on-health-care-resource-utilization
Other
Lääkkeiden riskinjakosopimukset Suomen sairaaloissa – kyselytutkimus 2019. Honkanen H, Snicker K and Ahlamaa J. Suomen Lääkärilehti 2019; 49:2872 – 2876.
Tutkimuksen uudet mahdollisuudet on huomioitava biopankkilaissa. Tuompo W, Hemmilä P, Ahlamaa J and Wolf M. Finnish Medical Journal (2018) 37: 2006-2007.
Read more:
Read summaries of real world evidence (RWE) studies here!
Find more information on real world evidence studies, RWE, RWD and related topics here!